Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Wrba, F."" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.
Autorzy:
Kappel-Latif S; 1Division of General Surgery, Department of Surgery, Research Laboratories, Medical University of Vienna, Vienna, Austria.
Zacherl J; 2Division of General Surgery, Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Hejna M; 3Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Westerhoff M; 4Department of Pathology, University of Michigan, Ann Arbor, MI USA.
Tamandl D; 5Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Ba-Ssalamah A; 5Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Mittlböck M; 6Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Wolf B; 1Division of General Surgery, Department of Surgery, Research Laboratories, Medical University of Vienna, Vienna, Austria.
Wrba F; 7Department of Pathology, Medical University of Vienna, Vienna, Austria.
Kührer I; 2Division of General Surgery, Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Pluschnig U; 3Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Schoppmann SF; 2Division of General Surgery, Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Függer R; 8Department of Surgery, Elisabethinen Hospital Linz, Linz, Austria.
Zwrtek R; Department of Surgery, Landesklinikum Mistelbach, Mistelbach, Austria.
Glaser K; 10Department of General‑, Visceral- and Tumor Surgery, Wilhelminenspital, Vienna, Austria.
Karner J; 11Department of Surgery, Kaiser Franz Josef Hospital, Vienna, Austria.
Längle F; Department of Surgery, Landesklinikum Wr. Neustadt, Wr. Neustadt, Austria.
Wenzl E; 13Department of General‑, Visceral- and Thoracic Surgery, Landeskrankenhaus Feldkirch, Feldkirch, Austria.
Roka R; 14Department of Surgery I, Krankenanstalt Rudolfstiftung, Vienna, Austria.
Öfner D; 15Department of Visceral- , Transplant- and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria.
Tschmelitsch J; Department of Surgery, Hospital Barmherzige Brüder St. Veit/Glan, St. Veit/Glan, Austria.
Hold M; 17Department of Surgery and Vascular Surgery, Hanusch Hospital, Vienna, Austria.
Keil F; Department of Hematology and Oncology, Landeskrankenhaus Leoben, Leoben, Austria.
Gnant M; 2Division of General Surgery, Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Kandioler D; 2Division of General Surgery, Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Corporate Authors:
Pancho trialists and for the Medical University of Vienna p53research group
Źródło:
European surgery : ACA : Acta chirurgica Austriaca [Eur Surg] 2018; Vol. 50 (4), pp. 160-166. Date of Electronic Publication: 2018 Jun 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies